Advancements in genomic sequencing have deepened our understanding of the genetic underpinnings of breast cancer, offering insights into why some cancers respond to immunotherapy while others do not. This knowledge paves the way for personalized treatment plans that leverage immunotherapy based on genetic markers, heralding a more targeted and effective approach to combating breast cancer.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.